Product Program year 2025 Source: CMS Open Payments

Hemangeol

Drug Pediatric Dermatology

NDC 64370-375-01

Open in the dashboard

General payments

$176,574

802 payments

Research payments

$0

0 payments

Through program year 2025, $176,574 in general payments and $0 in research payments were reported against Hemangeol (Pediatric Dermatology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $9,530 130
2024 General $53,230 159
2023 General $58,580 197
2022 General $22,526 114
2021 General $26,243 136
2020 General $6,466 66

Breakdown

Who paid General payments · program years 2020–2025
  1. Pierre Fabre Pharmaceuticals, Inc. $176,574 802 payments
Top recipients General payments · program year 2025
  1. Nationwide Childrens Hospital Teaching hospital · OH $2,000 21% · 1 payment
  2. U Of U Hospitals & Clinics Teaching hospital · UT $1,800 19% · 1 payment
  3. Cindy Daugherty Pediatrics · Wichita, KS $260 3% · 1 payment
  4. Teolinda Milsap Pediatrics · Wichita, KS $260 3% · 1 payment
  5. Melissa Jefferson Pediatric Hematology-Oncology · Kansas City, MO $260 3% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Dermatology $1,025 19% · 35 practitioners
  2. Pediatric Hematology-Oncology Pediatrics $874 16% · 17 practitioners
  3. Nurse Practitioner, Pediatrics Nurse Practitioner $661 12% · 6 practitioners
  4. Pediatrics $584 11% · 4 practitioners
  5. Pediatric Dermatology Dermatology $497 9% · 10 practitioners

The top 5 of 23 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Ohio $2,536 27% · 27 recipients
  2. Utah $1,840 19% · 2 recipients
  3. Missouri $545 6% · 3 recipients
  4. Colorado $520 5% · 2 recipients
  5. Kansas $520 5% · 2 recipients

The top 5 of 23 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

802 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record